“UCB, Inc., UCB Pharma GmbH, and LTS Lohmann Therapie-Systeme AG (collectively hereinafter “UCB”), and Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc., and Aurolife Pharma LLC (collectively hereinafter “Aurobindo”), the parties in the abovecaptioned action, have agreed to certain terms and conditions to resolve this action. Now the parties, by their respective undersigned attorneys, hereby stipulate and consent to entry of judgment and an injunction in the action, as follows: ORDERED, ADJUDGED AND DECREED as follows: 1. This District Court has jurisdiction over the subject matter of the above action and has personal jurisdiction over the parties. 2. As used in this Consent Judgment, (i) the term “Aurobindo Product” shall mean the drug product sold, offered for sale or distributed pursuant to ANDA No. 214903 (the “Aurobindo ANDA”) including any supplements or amendments thereto except for any such supplements or amendments that change the mode of administration, the active ingredient(s), or the composition of the drug product; (ii) the term “Licensed Patents” shall mean United States Patent Number 8,246,979; United States Patent Number 9,925,150; United States Patent Number 10,130,589; and United States Patent Number 10,350,174; and (iii) the term “Affiliate” shall mean any entity or person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with Aurobindo; for purposes of this definition, “control” means (a) ownership, directly or through one or more intermediaries, of (1) more than fifty percent (50%) of the shares of stock entitled to vote for the election of directors, in the case of a corporation, or (2) more than fifty percent (50%) of the equity interests in the case of any other type of legal entity or status as a general partner in any partnership, or (b) any other arrangement whereby an entity or person has the right to elect a majority of the Board of Directors or equivalent governing body of a corporation or other entity or the right to direct the management and policies of a corporation or other entity. 3. Unless otherwise specifically authorized by UCB, Aurobindo, including any of its Affiliates, successors and assigns, is enjoined from infringing the Licensed Patents, on its own part or through any Affiliate, by making, using, selling, offering to sell, importing or distributing of the Aurobindo Product. 4. Compliance with this Consent Judgment may be enforced by UCB and its successors in interest, or assigns. 5. This District Court retains jurisdiction to enforce or supervise performance under this Consent Judgment. 6. All claims and demands in this action are hereby dismissed with prejudice and without costs, disbursements or attorneys’ fees to any party.”